LAVAL, Québec--(BUSINESS WIRE)-- #Altasciences--Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, FizurexTM, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of FizurexTM toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has ad